Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SR 419

Next Previous
X
Search
Drug Profile

SR 419

Alternative Names: SR-419

Latest Information Update: 28 Sep 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SIMR Biotech
  • Class Analgesics; Non-opioid analgesics
  • Mechanism of Action Ion channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Neuropathic pain; Postherpetic neuralgia

Most Recent Events

  • 28 Sep 2024 No recent reports of development identified for phase-I development in Neuropathic-pain(In volunteers) in China (PO, Capsule)
  • 18 Jan 2023 SIMR Biotechnology completes a phase II trial in Postherpetic neuralgia in Australia (PO) and China (PO) (NCT05357677)
  • 02 Aug 2022 SIMR Biotech completes a phase I/II trial in Neuropathic pain in Australia (PO) (NCT04494815)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top